Literature DB >> 16414078

Peripheral neuropathies caused by mutations in the myelin protein zero.

Michael E Shy1.   

Abstract

Charcot-Marie-Tooth disease type 1B (CMT1B) is caused by mutations in the major PNS myelin protein myelin protein zero (MPZ). MPZ is a member of the immunoglobulin supergene family and functions as an adhesion molecule helping to mediate compaction of PNS myelin. Mutations in MPZ appear to either disrupt myelination during development, leading to severe early onset neuropathies, or to disrupt axo-glial interactions leading to late onset neuropathies in adulthood. Identifying molecular pathways involved in early and late onset CMT1B will be crucial to understand how MPZ mutations cause CMT1B so that rational therapies for both early and late onset neuropathies can be developed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16414078     DOI: 10.1016/j.jns.2005.11.015

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  31 in total

1.  Phylogenetically Conserved Sequences Around Myelin P0 Stop Codon are Essential for Translational Readthrough to Produce L-MPZ.

Authors:  Yoshihide Yamaguchi; Hiroko Baba
Journal:  Neurochem Res       Date:  2017-10-28       Impact factor: 3.996

2.  Myelin sheaths are formed with proteins that originated in vertebrate lineages.

Authors:  Robert M Gould; Todd Oakley; Jared V Goldstone; Jason C Dugas; Scott T Brady; Alexander Gow
Journal:  Neuron Glia Biol       Date:  2008-05

3.  Novel MPZ mutations and congenital hypomyelinating neuropathy.

Authors:  Hugh J McMillan; Sandro Santagata; Frederic Shapiro; Sat Dev Batish; Libby Couchon; Stephen Donnelly; Peter B Kang
Journal:  Neuromuscul Disord       Date:  2010-11       Impact factor: 4.296

4.  Loss- or Gain-of-Function Mutations in ACOX1 Cause Axonal Loss via Different Mechanisms.

Authors:  Hyung-Lok Chung; Michael F Wangler; Paul C Marcogliese; Juyeon Jo; Thomas A Ravenscroft; Zhongyuan Zuo; Lita Duraine; Sina Sadeghzadeh; David Li-Kroeger; Robert E Schmidt; Alan Pestronk; Jill A Rosenfeld; Lindsay Burrage; Mitchell J Herndon; Shan Chen; Amelle Shillington; Marissa Vawter-Lee; Robert Hopkin; Jackeline Rodriguez-Smith; Michael Henrickson; Brendan Lee; Ann B Moser; Richard O Jones; Paul Watkins; Taekyeong Yoo; Soe Mar; Murim Choi; Robert C Bucelli; Shinya Yamamoto; Hyun Kyoung Lee; Carlos E Prada; Jong-Hee Chae; Tiphanie P Vogel; Hugo J Bellen
Journal:  Neuron       Date:  2020-03-12       Impact factor: 17.173

5.  Gain of glycosylation: a new pathomechanism of myelin protein zero mutations.

Authors:  Valeria Prada; Mario Passalacqua; Maria Bono; Paola Luzzi; Sara Scazzola; Lucilla Alessandra Nobbio; Simona Capponi; Emilia Bellone; Paola Mandich; Gianluigi Mancardi; Michael Shy; Angelo Schenone; Marina Grandis
Journal:  Ann Neurol       Date:  2012-03       Impact factor: 10.422

6.  L-MPZ, a novel isoform of myelin P0, is produced by stop codon readthrough.

Authors:  Yoshihide Yamaguchi; Akiko Hayashi; Celia W Campagnoni; Akio Kimura; Takashi Inuzuka; Hiroko Baba
Journal:  J Biol Chem       Date:  2012-03-28       Impact factor: 5.157

7.  Enhanced axonal neuregulin-1 type-III signaling ameliorates neurophysiology and hypomyelination in a Charcot-Marie-Tooth type 1B mouse model.

Authors:  Cristina Scapin; Cinzia Ferri; Emanuela Pettinato; Desiree Zambroni; Francesca Bianchi; Ubaldo Del Carro; Sophie Belin; Donatella Caruso; Nico Mitro; Marta Pellegatta; Carla Taveggia; Markus H Schwab; Klaus-Armin Nave; M Laura Feltri; Lawrence Wrabetz; Maurizio D'Antonio
Journal:  Hum Mol Genet       Date:  2019-03-15       Impact factor: 6.150

8.  Clinical features and molecular modelling of novel MPZ mutations in demyelinating and axonal neuropathies.

Authors:  Paola Mandich; Paola Fossa; Simona Capponi; Alessandro Geroldi; Massimo Acquaviva; Rossella Gulli; Paola Ciotti; Fiore Manganelli; Marina Grandis; Emilia Bellone
Journal:  Eur J Hum Genet       Date:  2009-03-18       Impact factor: 4.246

9.  Erbin regulates NRG1 signaling and myelination.

Authors:  Yanmei Tao; Penggao Dai; Yu Liu; Sylvie Marchetto; Wen-Cheng Xiong; Jean-Paul Borg; Lin Mei
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-20       Impact factor: 11.205

10.  De Novo Variants in the ATPase Module of MORC2 Cause a Neurodevelopmental Disorder with Growth Retardation and Variable Craniofacial Dysmorphism.

Authors:  Maria J Guillen Sacoto; Iva A Tchasovnikarova; Erin Torti; Cara Forster; E Hallie Andrew; Irina Anselm; Kristin W Baranano; Lauren C Briere; Julie S Cohen; William J Craigen; Cheryl Cytrynbaum; Nina Ekhilevitch; Matthew J Elrick; Ali Fatemi; Jamie L Fraser; Renata C Gallagher; Andrea Guerin; Devon Haynes; Frances A High; Cara N Inglese; Courtney Kiss; Mary Kay Koenig; Joel Krier; Kristin Lindstrom; Michael Marble; Hannah Meddaugh; Ellen S Moran; Chantal F Morel; Weiyi Mu; Eric A Muller; Jessica Nance; Marvin R Natowicz; Adam L Numis; Bridget Ostrem; John Pappas; Carl E Stafstrom; Haley Streff; David A Sweetser; Marta Szybowska; Melissa A Walker; Wei Wang; Karin Weiss; Rosanna Weksberg; Patricia G Wheeler; Grace Yoon; Robert E Kingston; Jane Juusola
Journal:  Am J Hum Genet       Date:  2020-07-20       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.